| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 342,687 | 281,502 | 309,612 | 396,589 | | Cost of Revenue | 171,892 | 164,621 | 209,223 | 232,777 | | | Gross Profit | 170,795 | 116,881 | 100,389 | 163,812 | | | Operating Expenses | | Research Development | 78,209 | 79,227 | 82,609 | 95,266 | | Selling General and Administrative | 77,636 | 72,621 | 90,061 | 127,433 | | Non Recurring |
-
|
-
|
-
| 446,744 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,950 | (34,967) | (72,281) | (505,631) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,299 | 2,595 | 8,723 | 1,381 | | Earnings Before Interest And Taxes | 36,249 | (32,372) | (63,558) | (504,250) | | Interest Expense | 13,457 | 14,004 | 13,609 | 13,853 | | Income Before Tax | 22,792 | (46,376) | (77,167) | (518,103) | | Income Tax Expense | 2,387 | (20,800) | 5,660 | (83,849) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,405 | (25,576) | (82,827) | (434,254) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,405 | (25,576) | (82,827) | (434,254) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $20,405 | ($25,576) | ($82,827) | ($434,254) |
|
0.11% Nasdaq 0.00%
Income Statement
